glp-1 weight loss drug news november 2025 Poll: 1 in 8 Adults Say They Are Currently Taking a for Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Brain scientists are seeking weight-loss

Likewise, Mexicos 20242025 obesity rate of 37.1% highlights growing metabolic needs that strengthen North Americas dominance in this market

A 2024 Cornell University study found that households with at least one GLP-1 user reduced grocery spending by 5.3% within six months of starting treatment (CNBC, 2025)

J., Vilsbll, T

Why Must GLP-1 program Be Injectable

Studies with exenatide demonstrated that even a single dose could significantly reduce gallbladder contractions in healthy individuals

Billings, MD, MMSc Billings is the lead author of a Phase 2 clinical trial recently published in the journal Eloralintide is the name of the new medication produced by Eli Lilly and Company that is focused on in this clinical trial